Internal Medicine, Rheumatology · Arecibo, PR
NPI
1275706194
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Metro Pavia Health Clinic, Zona Industrial Victor Rojas II Carr129
Arecibo, PR, 00612
Phone (787) 650-0020
Medicare paid, 2022
$2,518
33 services
Medicare patients, 2022
16
Average age 72
Drug cost, 2024
$3.0M
5,482 prescriptions
Company payments, 2025
$14.11
From 1 companies
Procedures and visits billed to Original Medicare, 2022
In 2022, the most common Medicare service billed by Joel Ojeda-Rivera was code 99214 (office e&m - established), 21 times for 13 patients. In total Joel Ojeda-Rivera billed 33 services in 4 codes, and Medicare paid $2,518.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 21 | 13 | $89.06 | $1,870 |
Medicare prescription drug claims, 2024
In 2024, the drug Joel Ojeda-Rivera prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,053 prescriptions and refills. In total Joel Ojeda-Rivera wrote 5,482 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,053 | 1,071 | 198 | $12K |
| Duloxetine Hcl Generic | 832 | 872 | 248 | $11K |
| Prednisone Generic | 673 | 685 | 166 | $3,861 |
| Gabapentin Generic | 508 | 545 | 162 | $3,112 |
| Pregabalin Generic | 318 | 320 | 92 | $3,651 |
| Leflunomide Generic | 204 | 212 | 51 | $7,636 |
| Baclofen Generic | 201 | 201 | 154 | $1,131 |
| Meloxicam Generic | 169 | 171 | 74 | $659 |
| Hydroxychloroquine Sulfate Generic | 168 | 182 | 38 | $3,441 |
| Enbrel Sureclick Etanercept | 122 | 122 | 19 | $898K |
| Alendronate Sodium Generic | 92 | 97 | 21 | $511 |
| Xeljanz Xr Tofacitinib Citrate | 81 | 81 | Under 11 | $462K |
| Prolia Denosumab | 72 | 429 | 56 | $130K |
| Triamcinolone Acetonide Generic | 69 | 69 | 51 | $1,852 |
| Celecoxib Generic | 60 | 60 | 31 | $696 |
Brand drugs: 726 claims; generic drugs: 4,756 claims; opioid claims: 57.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joel Ojeda-Rivera $14.11 ($14.11 in general payments such as food, travel and fees) from 1 company. The largest payer was GlaxoSmithKline, LLC. with $14.11.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 1 | $14.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.